Lurasidone May Be Effective for Long-Term Treatment of Pediatric Bipolar Depression
In pediatric patients with bipolar I depression, long-term treatment with lurasidone 20 mg/day is effective in reducing depressive symptoms.
APA 2018
Intranasal Esketamine Effective for Geriatric Patients With Treatment-Resistant Depression
Intranasal esketamine in combination with oral antidepressants demonstrated significant reduction of depressive symptoms and improved overall severity of depressive illness and health-related quality of life and functioning.
Dasotraline Treatment Effective for ADHD-Related Symptoms and Behaviors in Children
In pediatric patients with ADHD, treatment with dasotraline 4 mg/day was effective in treating a range of ADHD-related symptoms and behaviors.
Antipsychotic Efficacy, Safety of ALKS 3831 Evaluated for Acute Schizophrenia
The phase 3 study assessed the antipsychotic efficacy and safety of ALKS 3831 in patients with acute exacerbations of schizophrenia.
Adjunctive Raloxifene vs Antipsychotics Alone for Schizophrenia, Schizoaffective Disorder
Adjunctive raloxifene may reduce negative symptom scores in women with schizophrenia or schizoaffective disorder.
Lofexidine Effective for Opioid Withdrawal Symptoms
Investigators pooled data from 2 phase 3 placebo-controlled studies to evaluate the safety and efficacy of lofexidine for opioid withdrawal symptoms.
Major Depressive Disorder Linked With Poorer Hospital Outcomes in Parkinson Disease
Investigators analyzed the differences in hospitalization outcomes, comorbidities, and utilization of procedures in patients with PD vs patients with PD and MDD.
Efficacy of Bupropion, Escitalopram for Internet Gaming Disorder in MDD
Bupropion had a greater effect on reducing impulsivity and attention symptoms than escitalopram.
Antipsychotics Increase Risk for Metabolic Syndrome, CVD in Younger Patients
Younger patients treated with antipsychotics after experiencing a first episode of psychosis are at an increased risk for metabolic syndrome and cardiovascular disease.
- Loading...
Loading...
Loading... 
Loading...